top | item 46971490

(no title)

intermerda | 19 days ago

> The study was on people age 50+,

So?

> In the US for adults 65+ (a key high-risk group in the trial), the ACIP preferentially recommends higher-antigen or adjuvanted options like Sanofi, Seqirus adjuvanted, recombinant high-antigen Flublok, etc as the "best-available standard of care",

Did this recommendation come before or after RFK Jr. fired all members of the ACIP and replaced them with his hand-picked choices? I suspect you already know the answer.

> * The "standard flu shot" Moderna used is likely not one of the above, or they would have said so

They didn't have to. The FDA told them they could continue to use standard flu shot if they wanted to as long as some statements were included in consent forms.

> The idea here is to see if the new shot is meaningfully better than the best existing/approved option for the target demographic, not to see if it's better than a standard shot you give a healthy 20-year-old.

No that's not the idea at all.

> All-in-all feels like a nothingburger.

No, it's not a nothingburger. It's a systematic assault on science and medicine.

discuss

order

alex43578|18 days ago

The recommendation came in 2022, before RFK, this trial, etc. Misrepresenting the truth doesn’t serve your argument.